LiMMTherapeuticsis a biopharmaceutical company focused on the development of therapeutic products for the treatment of inflammatory, infectious, and metabolic diseases.The company has a research center in Portugal with supporting ties with one of the most relevant European health foundations.
Pioneering discoveries on the regulation on Innate Lymphoid Cells (ILCs) by neuronal cell derived signaling;
Impressive team led by Henrique VeigaFernandes lab (Paul Allen Distinguished Investigator at Champalimaud Foundation in Portugal;
Biopharmaceutical company developing first-in-class therapeutic products –NRILs: neuronal reprogrammers of innate lymphocytes –to preserve health and treat inflammatory, infectious and metabolic diseases;
Exciting sustainable impact potential;
Investment date: 2021